CN104474456A - 一种用于治疗子宫肌瘤的中药丸 - Google Patents
一种用于治疗子宫肌瘤的中药丸 Download PDFInfo
- Publication number
- CN104474456A CN104474456A CN201410667540.5A CN201410667540A CN104474456A CN 104474456 A CN104474456 A CN 104474456A CN 201410667540 A CN201410667540 A CN 201410667540A CN 104474456 A CN104474456 A CN 104474456A
- Authority
- CN
- China
- Prior art keywords
- hysteromyoma
- treatment
- myoma
- pill
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010046798 Uterine leiomyoma Diseases 0.000 title claims abstract description 36
- 239000006187 pill Substances 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 55
- 229940079593 drug Drugs 0.000 claims abstract description 18
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 13
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229940116229 borneol Drugs 0.000 claims abstract description 13
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 13
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000004863 Frankincense Substances 0.000 claims abstract description 9
- 238000011282 treatment Methods 0.000 claims description 39
- 241000972155 Moschus Species 0.000 claims description 12
- 241000717739 Boswellia sacra Species 0.000 claims description 8
- 241000283956 Manis Species 0.000 claims description 8
- 241001057584 Myrrha Species 0.000 claims description 8
- 241000255626 Tabanus <genus> Species 0.000 claims description 8
- 230000000694 effects Effects 0.000 abstract description 31
- 238000002560 therapeutic procedure Methods 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 230000028327 secretion Effects 0.000 abstract description 3
- 210000001835 viscera Anatomy 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 230000012010 growth Effects 0.000 abstract description 2
- 206010061692 Benign muscle neoplasm Diseases 0.000 abstract 4
- 201000004458 Myoma Diseases 0.000 abstract 4
- 230000003902 lesion Effects 0.000 abstract 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 240000004467 Cryptotaenia canadensis Species 0.000 abstract 1
- 235000014260 Cryptotaenia canadensis Nutrition 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 21
- 208000002193 Pain Diseases 0.000 description 19
- 230000036407 pain Effects 0.000 description 19
- 208000029312 Muscular tumor Diseases 0.000 description 16
- 230000009471 action Effects 0.000 description 16
- 210000001015 abdomen Anatomy 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 13
- 230000000144 pharmacologic effect Effects 0.000 description 13
- 206010007247 Carbuncle Diseases 0.000 description 12
- 201000000736 Amenorrhea Diseases 0.000 description 11
- 206010001928 Amenorrhoea Diseases 0.000 description 11
- 231100000540 amenorrhea Toxicity 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 8
- 208000005171 Dysmenorrhea Diseases 0.000 description 7
- 206010013935 Dysmenorrhoea Diseases 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 210000004291 uterus Anatomy 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 230000005906 menstruation Effects 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 206010020880 Hypertrophy Diseases 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000012907 honey Nutrition 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000035935 pregnancy Effects 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000008451 emotion Effects 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010061245 Internal injury Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 201000010260 leiomyoma Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 208000009084 Cold Injury Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 108010074860 Factor Xa Proteins 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000032984 Intraoperative Complications Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000001833 anti-estrogenic effect Effects 0.000 description 1
- 230000003509 anti-fertility effect Effects 0.000 description 1
- 230000002223 anti-pathogen Effects 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000008339 endometrial blood flow Effects 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000000328 estrogen antagonist Substances 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 206010016629 fibroma Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000009802 hysterectomy Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 230000002632 myometrial effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000005220 pharmaceutical analysis Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 210000004999 sex organ Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
一种用于治疗子宫肌瘤的中药丸,由以下重量的原料药制成的药剂:琥珀25-35g、当归85-95g、赤芍55-65g、三棱55-65g、莪术55-65g、乳香40-50g、没药40-50g、麝香5-7g、梅片10-15g、北柴胡40-50g、穿山甲40-50g、王不留55-65g、虻虫40-50g。本发明药材均以天然野生药材配伍而成,功效全面,疗效卓越,可直达病灶,通过靶向病灶的深层治疗,有效将肌瘤根源撤除。本丸经内服后可消炎杀菌,抑制肌瘤生长,同时改善子宫内微环境,平衡内分泌,全面调理脏腑功能,使肌瘤不断地缩小,直至消失,且愈后有效杜绝复发。
Description
技术领域
本发明涉及中草药技术领域,具体涉及一种用于治疗子宫肌瘤的中药丸。
背景技术
子宫肌瘤是女性生殖器最常见的一种肿瘤。也是人体中最常见的肿瘤之一,又称为纤维肌瘤、子宫纤维瘤。由于子宫肌瘤主要是由子宫平滑肌细胞增生而成,其中有少量纤维结缔组织作为一种支持组织而存在,故称为子宫平滑肌瘤较为确切,简称子宫肌瘤。现代医学研究发现:肌瘤组织中的雌激素受体量较正常子宫肌组织多。提示子宫肌瘤的发生与长期的雌激素含量过高导致内分泌失调有关。同时激素代谢受高级神经中枢调控,故神经中枢活动对促进本病也可能起很重要的作用。子宫肌瘤确切病因不明,可能与体内雌激素水平过高,长期受雌激素刺激有关。中医认为,子宫肌瘤因七情内伤、脏腑功能失调、气滞血瘀而成。如果没有及时治疗可导致女性不孕、流产、尿频、排尿障碍等危害,是女性健康的一大杀手。与十几年前相比,子宫肌瘤越来越青睐三四十岁的中年女性,特别是未育、性生活失调和性情抑郁这三类女性。
中医认为子宫肌瘤的发病与七情所伤密切相关;如经期或产后外感风寒,或内伤生冷或郁怒伤肝造成正气内损、脏腑失和,日久而成“癞瘕”。治疗上应该本着治病求本的原则,以达到使身体从根本上康复的目的,而不是采取盲目的治疗方法。这样不仅延误病情,而且会错过治疗的最佳时机。
子宫肌瘤是育龄妇女的常见病,不仅发病率高,而且也是子宫切除的首要原因。虽然手术是治疗该病的有效方法,但由于手术风险、损伤和继发的缺憾,探索非手术疗法的尝试日益受到重视。现代医学非手术治疗子宫肌瘤,主要通过对抗雌激素活性抑制子宫肌瘤的生长,甚至使肌瘤缩小,从而减轻或缓解肌瘤相关症状,但一般不能消除及根治,往往停药后,随体内性激素水平的恢复而有肌瘤复发或再生长的可能。且尚未解决长(远)期或巩固疗效的问题,长期治疗的安全问题,治疗机制等问题。
中药治疗子宫肌瘤也有许多探索,桂枝茯苓丸是治疗子宫肌瘤的经典方剂,现代中药制剂如宫瘤清胶囊及一些自拟方剂,都在治疗子宫肌瘤方面进行了积极探索,但至今尚未见有被大家公认、疗效确切、可消除肌瘤的中药制剂。
发明内容
本发明所要解决的技术问题在于提供一种治愈率高,使用安全可靠的用于治疗子宫肌瘤的中药丸。
本发明所要解决的技术问题采用以下技术方案来实现:
一种用于治疗子宫肌瘤的中药丸,由以下重量的原料药制成的药剂:琥珀25-35g、当归85-95g、赤芍55-65g、三棱55-65g、莪术55-65g、乳香40-50g、没药40-50g、麝香5-7g、梅片10-15g、北柴胡40-50g、穿山甲40-50g、王不留55-65g、虻虫40-50g。
各原料药的优选重量为:琥珀30g、当归90g、赤芍60g、三棱60g、莪术60g、乳香45g、没药45g、麝香6g、梅片12g、北柴胡45g、穿山甲45g、王不留60g、虻虫45g。
本发明所用到的原料药可从普通中药店购买得到,其规格符合国家中药材标准即可。
用法用量:将上述药物粉碎,过1200目罗,梅片、麝香后入,和蜜为丸,一天三次,一次6g,一月一疗程。
注意事项:
1、忌食辛辣刺激食物。
2、服用期间避免再次怀孕,注意卫生,定期复查。
药物分析:
琥珀:
【药性】甘;平;无毒。归心;肝;小肠经;膀胱;肺;脾经。
【功效】镇惊安神;散瘀止血;利水通淋;去翳明目。
【药理作用】镇静安神、利尿。
【主治】惊悸失眠;惊风癫痫;血淋血尿;血滞经闭;产后瘀滞腹痛;癥瘕积聚;目生障翳;痈肿疮毒。
当归:
【药性】味辛;微甘;性微温。归肝、心、脾经。
【功效】活血调经;利尿。
【药理作用】根的水浸膏及挥发油具抑制子宫节律性收缩,对抗乙酰胆硷对子宫和肠道平滑肌的痉挛作用。
【主治】经闭;痛经;头晕;头痛;肢麻;水肿。
赤芍:
【药性】苦;微寒。归肝;脾经。
【功效】清热凉血;活血祛瘀
【药理作用】抗血栓形成作用,抗血小板聚集作用,抗肿瘤作用
【主治】温毒发斑;吐血衄血;肠风下血;目赤肿痛;痈肿疮疡;闭经;痛经;崩带淋浊;瘀滞胁痛;疝瘕积聚;跌扑损伤。
三棱:
【药性】味辛;涩;凉。归肝;脾经。
【功效】破血行气;消积止痛。
【药理作用】可引起肠管收缩加强,紧张性升高,对子宫也有兴奋作用。抑制血小板聚集、延长血栓形成时间、缩短血栓,长度和减轻重量的作用,还有延长凝血酶原时间及部分凝血致活酶的趋势,降低全血粘度。
【主治】症瘕痞块;瘀滞经闭;痛经;食积胀痛;跌年伤痛。
莪术:
【药性】味辛;苦;性温。归归肝、脾经。
【功效】行气破血;消积止痛。
【药理作用】抗肿瘤作用、抗早孕作用、抗菌作用、抑制血小板聚集和抗血栓。
【主治】血气心痛;饮食积滞;脘腹胀痛;血滞经闭;痛经;癥瘕瘤痞块;跌打损伤
乳香:
【药性】味辛;苦;微温。归心;肝;脾经。
【功效】活血行气;通经止痛;消肿生肌。
【药理作用】镇痛作用,消炎防腐作用。
【主治】心腹疼痛;风湿痹痛;经闭痛经;跌打瘀痛;痈疽肿毒;肠痈;疮溃不敛。
没药:
【药性】苦;平。归肝;脾;心;肾经。
【功效】活血止痛;消肿生肌。
【药理作用】镇痛,抗炎抗菌,细胞毒活性,保护粘膜。
【主治】胸腹瘀痛;痛经;经闭;癥瘕;跌打损伤;痈肿疮疡;肠痈;目赤肿痛。
麝香:
【药性】味辛;性温。归心;肝;脾经。
【功效】开窍醒神;活血散结;止痛消肿。
【药理作用】抗肿瘤作用、体液免疫和细胞免疫有增强作用、雄激素样作用、抗早孕作用、抗炎作用、增强中枢神经系统的耐缺氧能力。
【主治】热病宰昏;中风痰厥;气郁暴厥;中恶昏迷;血瘀经闭;癥瘕积聚;心腹急痛;跌打损伤;痹痛麻木;痈疽恶疮;喉痹;口疮;牙疳;脓耳。
梅片:
【药性】辛;苦;凉。归;肺经。
【功效】开窍醒神;散热止痛;明目去翳
【药理作用】:对中枢神经系统的作用、抗菌作用、抗生育作用。
【主治】中风口噤;热病神昏;惊痫痰迷;气闭耳聋;目赤翳膜;喉痹;口疮;痈肿;痔疮;蛲虫病。
北柴胡
【药性】味苦;辛;性微寒。归肝;胆经。
【功效】解表退热;疏肝解郁,升举阳气。
【药理作用】抗惊厥作用、解热镇痛作用、镇静作用、增强毛细血管作用、抗病原体作用、肾上腺引起皮质酮的合成和分泌、抗脂质过氧化的作用、免疫作用、抗肿瘤作用。
【主治】外感发热;寒热往来;疟疾;肝郁胁痛乳胀;头痛头眩;月经不调;气虚下陷之脱肛;子宫脱垂;胃下垂。
穿山甲:
【药性】味咸;性微寒。归肝;胃经。
【功效】活血散结;通经下乳;消痈溃坚。
【药理作用】降低血液粘度作用、抗炎作用、提高缺氧的耐受能力。
【主治】血瘀经闭;癥瘕;风湿痹痛;乳汁不下;痈肿;瘰疬。
王不留:
【药性】苦;性平。归肝;胃经。
【功效】活血通经;不乳消痈。
【药理作用】抗早孕作用、调节生理功能、影响体内代谢。
【主治】妇女经行腹痛;经闭;乳汁不通;乳痈;痈肿。
虻虫:
【药性】味苦;微咸;性凉;有毒。归肝经。
【功效】破血通经;逐瘀消癥。
【药理作用】抗凝作用、抗炎作用、镇痛作用、对子宫有兴奋作用。
【主治】血瘀经闭;产后恶露不尽;干血痨;少腹蓄血;癥瘕积块;跌打伤痛;痈肿;喉痹。
该疗法已在我所临床应用5余年,治疗患者500余例。并进行长期的跟踪回访,发现直径5cm以下一个疗程(一个月)即可明显见轻或治愈。月宫丸的优势就在于可免除手术带来的痛苦和西药激素对身体的危害,治标治本,从根本上解决问题。
月宫丸对子宫肌瘤有非常好的治疗效果,无需切除子宫,也无需高昂的费用。改善增生的子宫内膜的血液循环,使肌层的单纯性肥大逐渐消失,增生的结缔组织变软,从而起到调经、止血、疼痛消失、恢复卵巢功能的治疗作用,服用一个疗程下腹坠胀感消失,月经周期规律,阴道分泌物减少,疼痛感消失。B超显像痊愈,因此病不孕患者可生育。
月宫丸能有效地控制子宫肌瘤瘤体生长,使瘤体逐渐软化,最后消散。
本发明的有益效果是:本发明药材均以天然野生药材配伍而成,功效全面,疗效卓越,可直达病灶,通过靶向病灶的深层治疗,有效将肌瘤根源撤除。本丸经内服后可消炎杀菌,抑制肌瘤生长,同时改善子宫内微环境,平衡内分泌,全面调理脏腑功能,使肌瘤不断地缩小,直至消失,且愈后有效杜绝复发。
具体实施方式
为了使本发明实现的技术手段、创作特征、达成目的与功效易于明白了解,下面结合具体实施例,进一步阐述本发明。
实施例1
一种用于治疗子宫肌瘤的中药丸,由以下重量的原料药制成的药剂:琥珀30g、当归90g、赤芍60g、三棱60g、莪术60g、乳香45g、没药45g、麝香6g、梅片12g、北柴胡45g、穿山甲45g、王不留60g、虻虫45g。
本发明所用到的原料药可从普通中药店购买得到,其规格符合国家中药材标准即可。
用法用量:将上述药物粉碎,过1200目罗,梅片、麝香后入,和蜜为丸,一天三次,一次6g,一月一疗程。
实施例2
一种用于治疗子宫肌瘤的中药丸,由以下重量的原料药制成的药剂:琥珀35g、当归85g、赤芍65g、三棱55g、莪术65g、乳香40g、没药50g、麝香5g、梅片15g、北柴胡40g、穿山甲50g、王不留55g、虻虫50g。
本发明所用到的原料药可从普通中药店购买得到,其规格符合国家中药材标准即可。
用法用量:将上述药物粉碎,过1200目罗,梅片、麝香后入,和蜜为丸,一天三次,一次6g,一月一疗程。
实施例3
一种用于治疗子宫肌瘤的中药丸,由以下重量的原料药制成的药剂:琥珀25g、当归95g、赤芍55g、三棱65g、莪术55g、乳香50g、没药40g、麝香7g、梅片10g、北柴胡50g、穿山甲40g、王不留65g、虻虫40g。
本发明所用到的原料药可从普通中药店购买得到,其规格符合国家中药材标准即可。
用法用量:将上述药物粉碎,过1200目罗,梅片、麝香后入,和蜜为丸,一天三次,一次6g,一月一疗程。
病例1
王某某,女,36岁,患有子宫肌瘤一年多,月经量大,经血颜色深有血块,经期腹痛、口干,脸上有色斑,经常头晕,四肢无力。一年前B超检查结果为子宫肌瘤(肌壁间),大小约3.0×2.1cm。最近B超提示为:子宫肌瘤3.7×2.7cm大小。经过问诊,发现患者的子宫肌瘤属于肝郁气滞型的,患者平时很容易生气,而且有事情老是憋在心里,所以特别提醒患者要控制自己的情绪,多与朋友、亲戚沟通,不要积郁于心里。给予王女士月宫丸一个疗程,现查B超子宫肌瘤大小1.0×0.5cm。后又进行了一个疗程的治疗后来我院复诊,月经正常,量减少约两成,无痛经,精神较前已明显好转,面色红润,查B超肌瘤消失。近半年随访无复发。
病例2
吴某某,女,41岁,2009年检查出子宫肌瘤,左前壁可见4.0×4.1cm,右侧壁可见3.8×3.1cm两个大小不等的肌瘤。做了肌瘤剔除手术。手术一年半后肌瘤复发。医生提出再次手术,吴女士通过查询资料得知,手术复发率大,决定药物保守治疗。诊疗情况:经月宫丸治疗一个疗程后,复查最大瘤体为1.7×1.6cm。因疗效显著,继续治疗一个疗程,B超复查肌瘤消失,现已停止治疗两年,无复发现象。
病例3
刘某某,女,35岁,经常便秘,发现自己不仅胖了,小肚子也越来越硬,除了便秘,还有白带异常和痛经的症状。她来到医院检查后,结果被确诊为子宫肌瘤2.7×2.6cm,经本院月宫丸给予治疗,三天后便秘感消失,经过一个月积极配合治疗,腹部由硬质转松软,白带由腥臭暗黄转为少量,经期腹痛明显好转,B超查之肌瘤消失。
病例4
李丽,女,32岁,正处在备孕状态,在孕前检查的时候,发现在子宫内有一个将近3.0×2.8cm的子宫肌瘤,一心想要生宝宝的她决定先不管该肌瘤,等生孩子之后才慢慢进行治疗。可是医生却告诉她:子宫肌瘤不治疗会影响生育,导致流产、早产、或者难产。为规避风险及手术损伤愿以保守治疗。服用月宫丸一个疗程各种症状均有明显改善、好转,肤色白里透红,光泽亮丽。B超查:肌瘤1.7×1.5cm。李女士提出巩固治疗加强一个疗程。三个月后肌瘤消失。半后顺利怀孕,现待产期间。
以上显示和描述了本发明的基本原理和主要特征和本发明的优点。本行业的技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下,本发明还会有各种变化和改进,这些变化和改进都落入要求保护的本发明范围内。本发明要求保护范围由所附的权利要求书及其等效物界定。
Claims (2)
1.一种用于治疗子宫肌瘤的中药丸,其特征在于,由以下重量的原料药制成的药剂:琥珀25-35g、当归85-95g、赤芍55-65g、三棱55-65g、莪术55-65g、乳香40-50g、没药40-50g、麝香5-7g、梅片10-15g、北柴胡40-50g、穿山甲40-50g、王不留55-65g、虻虫40-50g。
2.根据权利要求1所述的一种用于治疗子宫肌瘤的中药丸,其特征在于,由以下重量的原料药制成的药剂:琥珀30g、当归90g、赤芍60g、三棱60g、莪术60g、乳香45g、没药45g、麝香6g、梅片12g、北柴胡45g、穿山甲45g、王不留60g、虻虫45g。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410667540.5A CN104474456B (zh) | 2014-11-20 | 2014-11-20 | 一种用于治疗子宫肌瘤的中药丸 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410667540.5A CN104474456B (zh) | 2014-11-20 | 2014-11-20 | 一种用于治疗子宫肌瘤的中药丸 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104474456A true CN104474456A (zh) | 2015-04-01 |
CN104474456B CN104474456B (zh) | 2017-12-22 |
Family
ID=52749157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410667540.5A Active CN104474456B (zh) | 2014-11-20 | 2014-11-20 | 一种用于治疗子宫肌瘤的中药丸 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104474456B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109248301A (zh) * | 2018-11-13 | 2019-01-22 | 广西志诚孝善三商贸有限公司 | 可调节内分泌系统和平衡荷尔蒙分泌的妇科凝胶 |
CN109248302A (zh) * | 2018-11-14 | 2019-01-22 | 广西志诚孝善三商贸有限公司 | 妇科用可平衡内分泌的形体调理凝胶 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1140079A (zh) * | 1996-02-13 | 1997-01-15 | 徐万奇 | 治疗宫颈癌、妇科炎症的方剂及泡制方法 |
CN101972445A (zh) * | 2010-07-13 | 2011-02-16 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗子宫肌瘤的中药组合物及其制备方法 |
-
2014
- 2014-11-20 CN CN201410667540.5A patent/CN104474456B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1140079A (zh) * | 1996-02-13 | 1997-01-15 | 徐万奇 | 治疗宫颈癌、妇科炎症的方剂及泡制方法 |
CN101972445A (zh) * | 2010-07-13 | 2011-02-16 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗子宫肌瘤的中药组合物及其制备方法 |
Non-Patent Citations (3)
Title |
---|
姬云海: "消瘤丸治疗子宫肌瘤168例", 《湖北中医杂志》 * |
招泽熙: "中医辨证治疗子宫肌瘤39例", 《湖南中医药导报》 * |
马丽雅等: "妇疾康阴道给药法治疗子宫肌瘤82例临床研究", 《中国实验方剂学杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109248301A (zh) * | 2018-11-13 | 2019-01-22 | 广西志诚孝善三商贸有限公司 | 可调节内分泌系统和平衡荷尔蒙分泌的妇科凝胶 |
CN109248302A (zh) * | 2018-11-14 | 2019-01-22 | 广西志诚孝善三商贸有限公司 | 妇科用可平衡内分泌的形体调理凝胶 |
Also Published As
Publication number | Publication date |
---|---|
CN104474456B (zh) | 2017-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104398998A (zh) | 一种治疗泌尿系结石的中药组合物 | |
CN104189871A (zh) | 一种治疗骨质增生的药酒 | |
CN102949569A (zh) | 一种治疗前列腺增生引起尿频、尿急、尿痛的中药组合物 | |
CN102973677B (zh) | 一种治疗卵巢囊肿的中药 | |
CN104383514A (zh) | 一种治疗宫颈癌的中药 | |
CN101569738A (zh) | 一种治疗乳腺炎、乳腺增生、乳房肿块、关节积液、跌打损伤的膏药及其制备方法与应用 | |
CN104474456B (zh) | 一种用于治疗子宫肌瘤的中药丸 | |
CN103007093A (zh) | 一种治疗妇科炎症的药物及其制备方法 | |
CN102784229A (zh) | 一种治疗运动损伤和风湿型骨关节病外用熏洗中药 | |
CN102772699B (zh) | 一种治疗慢性盆腔炎的中药组合物 | |
CN104689279A (zh) | 一种用于子宫腺肌病的中药制剂及制备方法 | |
CN104225490A (zh) | 一种治疗胆囊炎的中药 | |
CN103610772B (zh) | 治疗脑血栓的中药 | |
CN105853930A (zh) | 一种治疗抑郁症的中药组合物 | |
CN109248301A (zh) | 可调节内分泌系统和平衡荷尔蒙分泌的妇科凝胶 | |
CN104784592A (zh) | 一种治疗输卵管堵塞的中药 | |
CN109248302A (zh) | 妇科用可平衡内分泌的形体调理凝胶 | |
CN107982476A (zh) | 一种用于治疗宫颈癌的丸剂药物及其制备方法 | |
CN103055268B (zh) | 一种治疗子宫内膜异位症的中药组合物 | |
CN105688056A (zh) | 一种治疗泌尿系结石的药物及其制备方法 | |
CN101417024B (zh) | 一种治疗子宫内膜异位症的药物组合物 | |
CN103550591B (zh) | 一种治疗乳腺增生的中药组合物 | |
CN105853782A (zh) | 一种治疗子宫脱垂的中药组合物 | |
CN104623553A (zh) | 一种治疗附件炎的中药组合物 | |
CN103933390B (zh) | 一种治疗乳腺囊性增生的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231206 Address after: No. 7, Liujiang Administrative Village, Dayang Town, Qiaocheng District, Bozhou City, Anhui Province, 236800 Patentee after: Liu Kun Address before: No. 126 Daqiao South Road, Jieshou City, Fuyang City, Anhui Province, 236500 Patentee before: JIESHOU ORTHOPAEDIC Hospital |